A bad bug takes on a new role as a cause of ventilator-associated pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 1, 2008, Pages 1-2

  Anaissie, Elias J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE;

ASPERGILLUS; BACTERIUM IDENTIFICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; EDITORIAL; HEMOSIDEROSIS; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; LUNG LAVAGE; PATHOGENESIS; PRIORITY JOURNAL; VENTILATOR ASSOCIATED PNEUMONIA;

ASPERGILLOSIS; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE FLUID; CROSS INFECTION; HOSPITAL MORTALITY; INTENSIVE CARE UNITS; LUNG DISEASES, FUNGAL; MANNANS; OPPORTUNISTIC INFECTIONS; PNEUMONIA, VENTILATOR-ASSOCIATED; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE;

EID: 37849049020     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200710-1482ED     Document Type: Editorial

References (13)

1. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
2. Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, Spriet I, Verbeken E, Van Wijngaerden E. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008;177:27-34.
3. Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007;45:205-216.
4. Dimopoulos G, Piagnerelli M, Berre J, Eddafali B, Salmon I, Vincent JL. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003;15:71-75.
5. Vogeser M, Wanders A, Haas A, Ruckdeschel G. A four-year review of fatal aspergillosis. Eur J Clin Microbiol Infect Dis 1999;18:42-45.
6. Janssen JJ, Strack van Schijndel RJ, van der Poest Clement EH, Ossenkoppele GJ, Thijs LG, Neuerburg JM, Günther RW, Vorwerk D, Dondelinger RF, et al. Outcome of ICU treatment in invasive aspergillosis. Intensive Care Med 1996;22:1315-1322.
7. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007;30:782-800.
8. Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006;173:707-717.
9. Anaissie EJ. Trial design for mould-active agents: time to break the mold aspergillosis in neutropenic adults. Clin Infect Dis 2007;44:1298-1306.
10. Woods G, Miceli MH, Grazziutti ML, Zhao W, Barlogie B, Anaissie E. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. Cancer 2007;110:830-834.
11. Miceli MH, Maertens J, Buve K, Grazziutti M, Woods G, Rahman M, Barlogie B, Anaissie EJ. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: proof of principle, description, and clinical and research implications. Cancer 2007;110:112-120.
12. Lassoued S, Sire S, Farny M, Billey T, Lassoued K. Pulmonary aspergillosis in a patient with rheumatoid arthritis treated by etanercept. Clin Exp Rheumatol 2004;22:267-268.
13. Rychly DJ, DiPiro JT. Infections associated with tumor necrosis factor-alpha antagonists. Pharmacotherapy 2005;25:1181-1192.